Market Cap

CellaVision AB Market Capitalization:

kr4.98 Billion

SEK as of Jan. 1, 2024

US$495.1 Million

business CellaVision AB Company Profile

CellaVision AB Main Stock Listing

OMX: CEVI

Market Capitalization History of CellaVision AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $192.67 B
Stryker Corporation $113.24 B
Medtronic $111.60 B
Boston Scientific Corporation $85.22 B
Shenzhen Mindray Bio-Medical Electronics Co. Ltd $49.33 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of CellaVision AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr4.98 B -9.62%
Jan. 1, 2023 kr5.51 B -25.64%
Jan. 1, 2022 kr7.42 B 2.09%
Jan. 1, 2021 kr7.26 B -11.12%
Jan. 1, 2020 kr8.17 B 37.58%
Jan. 1, 2019 kr5.94 B 54.69%
Jan. 1, 2018 kr3.84 B 59.09%
Jan. 1, 2017 kr2.41 B 54.51%
Jan. 1, 2016 kr1.56 B 54.36%
Jan. 1, 2015 kr1.01 B 115.10%
Jan. 1, 2014 kr470.6 M 20.00%
Jan. 1, 2013 kr392.1 M 15.11%
Jan. 1, 2012 kr340.7 M 3.35%
Jan. 1, 2011 kr329.6 M -4.61%
Jan. 1, 2010 kr345.6 M 168.57%
Jan. 1, 2009 kr128.7 M 15.64%
Jan. 1, 2008 kr111.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

CellaVision AB Categories

Sweden languages Healthcare languages Medical Devices
Sweden Healthcare Sweden Medical Devices

Stocks & Indices

CellaVision AB has the following listings and related stock indices.


Stock: OMX: CEVI

Stock: FSX: C26

Stock: OTC: CLVSF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.